The FDA in U.S. has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence rates compared to other PrEP medications and with minimal side effects.
The Bill and Melinda Gates Foundation’s first Goalkeepers report covers 18 data points from the UN Sustainable Development Goals, from infant mortality to family planning to diseases like HIV, malaria, and tuberculosis.
